Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lieping Chen

Showing results (1-10 of 304) with videos related to

Pageof 31
Sort By:
Nature Reviews. Immunology|May 4, 2004
Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunityLieping Chen
Nature Medicine|May 5, 2025
PD-L1 and the dawn of modern cancer immunotherapyLieping Chen
Nature Medicine|April 3, 2002
Antibody gene therapy: old wine in a new bottleLieping Chen
Cancer Journal (Sudbury, Mass.)|August 8, 2014
From the guest editor: Tumor site immune modulation therapyLieping Chen
The Journal of Investigative Dermatology|October 17, 2014
Myeloid cells' evasion of melanoma immunityJun Wang, Lieping Chen
JAMA Oncology|August 5, 2016
Classification of Advanced Human Cancers Based on Tumor Immunity in the MicroEnvironment (TIME) for Cancer ImmunotherapyYu Zhang, Lieping Chen
Journal for Immunotherapy of Cancer|August 27, 2025
Why has immune "checkpoint" therapy failed in most clinical trials?Xuan Yang, Lieping Chen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2025
B7-H3 as a Universal Target for Solid Tumor Therapy: Clinical Promise and Biological ComplexityBaozhu Huang, Lieping Chen
Microbes and Infection|June 23, 2004
Co-signaling molecules of the B7-CD28 family in positive and negative regulation of T lymphocyte responsesShengdian Wang, Lieping Chen
European Journal of Immunology|February 6, 2013
Adaptive resistance: a tumor strategy to evade immune attackSheng Yao, Lieping Chen
Pageof 31

Showing results (1-10 of 304) with videos related to

Sort By:
Pageof 31
Nature Reviews. Immunology|May 4, 2004
Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunityLieping Chen
Nature Medicine|May 5, 2025
PD-L1 and the dawn of modern cancer immunotherapyLieping Chen
Nature Medicine|April 3, 2002
Antibody gene therapy: old wine in a new bottleLieping Chen
Cancer Journal (Sudbury, Mass.)|August 8, 2014
From the guest editor: Tumor site immune modulation therapyLieping Chen
The Journal of Investigative Dermatology|October 17, 2014
Myeloid cells' evasion of melanoma immunityJun Wang, Lieping Chen
JAMA Oncology|August 5, 2016
Classification of Advanced Human Cancers Based on Tumor Immunity in the MicroEnvironment (TIME) for Cancer ImmunotherapyYu Zhang, Lieping Chen
Journal for Immunotherapy of Cancer|August 27, 2025
Why has immune "checkpoint" therapy failed in most clinical trials?Xuan Yang, Lieping Chen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 16, 2025
B7-H3 as a Universal Target for Solid Tumor Therapy: Clinical Promise and Biological ComplexityBaozhu Huang, Lieping Chen
Microbes and Infection|June 23, 2004
Co-signaling molecules of the B7-CD28 family in positive and negative regulation of T lymphocyte responsesShengdian Wang, Lieping Chen
European Journal of Immunology|February 6, 2013
Adaptive resistance: a tumor strategy to evade immune attackSheng Yao, Lieping Chen
Pageof 31